clinical trial · NCT06992258
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Criterium, Inc.·phase2·recruiting·n = 120
Colorectal CancerFruquintinib+ Lonsurf (trifluridine and tipiracil)Fruquintinib
brief summary
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients with Refractory Advanced/Metastatic Microsatellite Stable Colorectal Cancer
started
Oct 27, 2025
primary completion
Dec 31, 2027
completion
Dec 31, 2028
last updated
Mar 17, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol